143 related articles for article (PubMed ID: 9149748)
21. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia.
Viganò GL; Mannucci PM; Lattuada A; Harris A; Remuzzi G
Am J Hematol; 1989 May; 31(1):32-5. PubMed ID: 2705441
[TBL] [Abstract][Full Text] [Related]
22. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome.
Artoni A; Bassotti A; Abbattista M; Marinelli B; Lecchi A; Gianniello F; Clerici M; Bucciarelli P; La Marca S; Peyvandi F; Martinelli I
J Thromb Haemost; 2018 Dec; 16(12):2425-2431. PubMed ID: 30312027
[TBL] [Abstract][Full Text] [Related]
23. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome.
Cordova A; Barrios NJ; Ortiz I; Rivera E; Cadilla C; Santiago-Borrero PJ
Pediatr Blood Cancer; 2005 Jan; 44(1):51-4. PubMed ID: 15368543
[TBL] [Abstract][Full Text] [Related]
24. Effect of deamino-8-D-arginine desmopressin in uremic bleeding.
Hong SY; Yang DH
Korean J Intern Med; 1996 Jun; 11(2):145-50. PubMed ID: 8854651
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
26. Easy bruisability, aspirin intolerance, and response to DDAVP.
Lekas MD; Crowley JP
Laryngoscope; 1993 Feb; 103(2):156-9. PubMed ID: 8426506
[TBL] [Abstract][Full Text] [Related]
27. Effect of 1-deamino-8-D-arginine vasopressin on the prolonged bleeding time in chronic renal failure.
Watson AJ; Keogh JA
Nephron; 1982; 32(1):49-52. PubMed ID: 6817151
[TBL] [Abstract][Full Text] [Related]
28. Effects of desmopressin on hemostasis in patients with liver cirrhosis.
Agnelli G; Parise P; Levi M; Cosmi B; Nenci GG
Haemostasis; 1995; 25(5):241-7. PubMed ID: 7489963
[TBL] [Abstract][Full Text] [Related]
29. Effects of desmopressin acetate (DDAVP) and dextran on hemostatic and thromboprophylactic mechanisms.
Lethagen S; Rugarn P; Aberg M; Nilsson IM
Acta Chir Scand; 1990 Sep; 156(9):597-602. PubMed ID: 1702252
[TBL] [Abstract][Full Text] [Related]
30. Clotting factor XIII and desmopressin improve hemostasis in uncontrolled bleeding.
Carreiro PR; Rezende-Neto JB; Lisboa Tde A; Ribeiro DD; Camargos ER; Andrade MV; Rizoli SB; Melo JR
Acta Cir Bras; 2015 Mar; 30(3):170-7. PubMed ID: 25790004
[TBL] [Abstract][Full Text] [Related]
31. DDAVP: a useful alternative to blood components in moderate hemophilia A and von Willebrand disease.
Warrier AI; Lusher JM
J Pediatr; 1983 Feb; 102(2):228-33. PubMed ID: 6401806
[TBL] [Abstract][Full Text] [Related]
32. Management of Hemorrhage During Cesarean Delivery in a Patient With Vascular Ehlers-Danlos Syndrome: A Case Report.
Grant O; Mulligan K; Donnelly J; Ní Áinle F; Mhuircheartaigh RN
A A Pract; 2023 Jan; 17(1):e01655. PubMed ID: 36706158
[TBL] [Abstract][Full Text] [Related]
33. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
34. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair.
Vucelić D; Golubović M; Bjelović M
Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257
[TBL] [Abstract][Full Text] [Related]
35. Use of DDAVP in inherited and acquired platelet dysfunction.
DiMichele DM; Hathaway WE
Am J Hematol; 1990 Jan; 33(1):39-45. PubMed ID: 2293761
[TBL] [Abstract][Full Text] [Related]
36. Effects of DDAVP administrated subcutaneously in dogs with aspirin-induced platelet dysfunction and hemostatic impairment due to chronic liver diseases.
Sakai M; Watari T; Miura T; Maruyama H; Koie H; Yamaya Y; Takeuchi A; Hasegawa A
J Vet Med Sci; 2003 Jan; 65(1):83-6. PubMed ID: 12576709
[TBL] [Abstract][Full Text] [Related]
37. Study on mechanisms of a haemostatic effect of 1 deamino-8-D-arginine vasopressin (desmopressin) in uraemic patients.
Malyszko J; Pietraszek M; Buczko W; Mysliwiec M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):319-24. PubMed ID: 1697836
[TBL] [Abstract][Full Text] [Related]
38. Characterization of bleeding symptoms in Ehlers-Danlos syndrome.
Kumskova M; Flora GD; Staber J; Lentz SR; Chauhan AK
J Thromb Haemost; 2023 Jul; 21(7):1824-1830. PubMed ID: 37179130
[TBL] [Abstract][Full Text] [Related]
39. Hemostatic and fibrinolytic response to desmopressin in uremic patients.
Chen KS; Huang CC; Leu ML; Deng P; Lo SK
Blood Purif; 1997; 15(2):84-91. PubMed ID: 9087815
[TBL] [Abstract][Full Text] [Related]
40. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.
Leissinger C; Carcao M; Gill JC; Journeycake J; Singleton T; Valentino L
Haemophilia; 2014 Mar; 20(2):158-67. PubMed ID: 23937614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
